The role of growth regulatory aberrations in progression of human colon carcinoma

Gillian M. Howell, Luzhe Sun, Barry L. Ziober, Shao Ping Wu, Michael G. Brattain

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Colon carcinoma is a multistage disease. Most malignancies arise from pre-existing benign tumors. Multiple chromosomal defects affecting oncogene and tumor suppressor gene function are associated with disease progression. These aberrations result in an imbalance between the normal positive and negative growth effectors, which contribute further to disease progression. We have studied how changes in the expression of TGFα and TGFβ affect colon carcinoma cell behavior. Overexpression of the stimulatory factor TGFα in a relatively benign cell line with weak TGFα autocrine activity converted the cell type to an aggressive, progressed phenotype in vivo and in vitro. In contrast, disruption of TGFα expression by constitutive expression of TGFα antisense RNA in a progressed cell line with a strong, internalized autocrine loop resulted in the development of clones with decreased tumorigenicity in vitro and in vivo. Suppression of the inhibitory effects of TGFβ by constitutive expression of TGFβ antisense RNA increased the tumorigenicity of the cell lines in vitro and in vivo. None of these alterations in TGFα or TGFβ expression affected the doubling time of the cells. The changes in tumorigenicity were due to effects on the lag phase of growth. We conclude that TGFβ functions to maintain the cells in a quiescent state while TGFα drives reentry into the cell cycle. We have identified a unique cis-element that mediates TGFα autoregulation. The transcription factor binding this element is also involved in the cell-cycle regulation of TGFα expression. We hypothesize that this factor may be a convergent point TGFα and TGFβ interact in controlling movement into and out of quiescence.

Original languageEnglish (US)
Pages (from-to)275-286
Number of pages12
JournalCancer and Metastasis Reviews
Volume12
Issue number3-4
DOIs
StatePublished - Sep 1993
Externally publishedYes

Fingerprint

Colon
Carcinoma
Antisense RNA
Growth
Cell Line
Disease Progression
Cell Cycle
Tumor Suppressor Genes
Oncogenes
Neoplasms
Homeostasis
Transcription Factors
Clone Cells
Phenotype
In Vitro Techniques

Keywords

  • colon cancer
  • differentiation
  • expression
  • progression
  • regulation
  • transcription factors
  • transforming growth factor α
  • transforming growth factor β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The role of growth regulatory aberrations in progression of human colon carcinoma. / Howell, Gillian M.; Sun, Luzhe; Ziober, Barry L.; Wu, Shao Ping; Brattain, Michael G.

In: Cancer and Metastasis Reviews, Vol. 12, No. 3-4, 09.1993, p. 275-286.

Research output: Contribution to journalArticle

Howell, Gillian M. ; Sun, Luzhe ; Ziober, Barry L. ; Wu, Shao Ping ; Brattain, Michael G. / The role of growth regulatory aberrations in progression of human colon carcinoma. In: Cancer and Metastasis Reviews. 1993 ; Vol. 12, No. 3-4. pp. 275-286.
@article{fb4b1a3bb6bd409ca214ea0dbfb2a93a,
title = "The role of growth regulatory aberrations in progression of human colon carcinoma",
abstract = "Colon carcinoma is a multistage disease. Most malignancies arise from pre-existing benign tumors. Multiple chromosomal defects affecting oncogene and tumor suppressor gene function are associated with disease progression. These aberrations result in an imbalance between the normal positive and negative growth effectors, which contribute further to disease progression. We have studied how changes in the expression of TGFα and TGFβ affect colon carcinoma cell behavior. Overexpression of the stimulatory factor TGFα in a relatively benign cell line with weak TGFα autocrine activity converted the cell type to an aggressive, progressed phenotype in vivo and in vitro. In contrast, disruption of TGFα expression by constitutive expression of TGFα antisense RNA in a progressed cell line with a strong, internalized autocrine loop resulted in the development of clones with decreased tumorigenicity in vitro and in vivo. Suppression of the inhibitory effects of TGFβ by constitutive expression of TGFβ antisense RNA increased the tumorigenicity of the cell lines in vitro and in vivo. None of these alterations in TGFα or TGFβ expression affected the doubling time of the cells. The changes in tumorigenicity were due to effects on the lag phase of growth. We conclude that TGFβ functions to maintain the cells in a quiescent state while TGFα drives reentry into the cell cycle. We have identified a unique cis-element that mediates TGFα autoregulation. The transcription factor binding this element is also involved in the cell-cycle regulation of TGFα expression. We hypothesize that this factor may be a convergent point TGFα and TGFβ interact in controlling movement into and out of quiescence.",
keywords = "colon cancer, differentiation, expression, progression, regulation, transcription factors, transforming growth factor α, transforming growth factor β",
author = "Howell, {Gillian M.} and Luzhe Sun and Ziober, {Barry L.} and Wu, {Shao Ping} and Brattain, {Michael G.}",
year = "1993",
month = "9",
doi = "10.1007/BF00665958",
language = "English (US)",
volume = "12",
pages = "275--286",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "3-4",

}

TY - JOUR

T1 - The role of growth regulatory aberrations in progression of human colon carcinoma

AU - Howell, Gillian M.

AU - Sun, Luzhe

AU - Ziober, Barry L.

AU - Wu, Shao Ping

AU - Brattain, Michael G.

PY - 1993/9

Y1 - 1993/9

N2 - Colon carcinoma is a multistage disease. Most malignancies arise from pre-existing benign tumors. Multiple chromosomal defects affecting oncogene and tumor suppressor gene function are associated with disease progression. These aberrations result in an imbalance between the normal positive and negative growth effectors, which contribute further to disease progression. We have studied how changes in the expression of TGFα and TGFβ affect colon carcinoma cell behavior. Overexpression of the stimulatory factor TGFα in a relatively benign cell line with weak TGFα autocrine activity converted the cell type to an aggressive, progressed phenotype in vivo and in vitro. In contrast, disruption of TGFα expression by constitutive expression of TGFα antisense RNA in a progressed cell line with a strong, internalized autocrine loop resulted in the development of clones with decreased tumorigenicity in vitro and in vivo. Suppression of the inhibitory effects of TGFβ by constitutive expression of TGFβ antisense RNA increased the tumorigenicity of the cell lines in vitro and in vivo. None of these alterations in TGFα or TGFβ expression affected the doubling time of the cells. The changes in tumorigenicity were due to effects on the lag phase of growth. We conclude that TGFβ functions to maintain the cells in a quiescent state while TGFα drives reentry into the cell cycle. We have identified a unique cis-element that mediates TGFα autoregulation. The transcription factor binding this element is also involved in the cell-cycle regulation of TGFα expression. We hypothesize that this factor may be a convergent point TGFα and TGFβ interact in controlling movement into and out of quiescence.

AB - Colon carcinoma is a multistage disease. Most malignancies arise from pre-existing benign tumors. Multiple chromosomal defects affecting oncogene and tumor suppressor gene function are associated with disease progression. These aberrations result in an imbalance between the normal positive and negative growth effectors, which contribute further to disease progression. We have studied how changes in the expression of TGFα and TGFβ affect colon carcinoma cell behavior. Overexpression of the stimulatory factor TGFα in a relatively benign cell line with weak TGFα autocrine activity converted the cell type to an aggressive, progressed phenotype in vivo and in vitro. In contrast, disruption of TGFα expression by constitutive expression of TGFα antisense RNA in a progressed cell line with a strong, internalized autocrine loop resulted in the development of clones with decreased tumorigenicity in vitro and in vivo. Suppression of the inhibitory effects of TGFβ by constitutive expression of TGFβ antisense RNA increased the tumorigenicity of the cell lines in vitro and in vivo. None of these alterations in TGFα or TGFβ expression affected the doubling time of the cells. The changes in tumorigenicity were due to effects on the lag phase of growth. We conclude that TGFβ functions to maintain the cells in a quiescent state while TGFα drives reentry into the cell cycle. We have identified a unique cis-element that mediates TGFα autoregulation. The transcription factor binding this element is also involved in the cell-cycle regulation of TGFα expression. We hypothesize that this factor may be a convergent point TGFα and TGFβ interact in controlling movement into and out of quiescence.

KW - colon cancer

KW - differentiation

KW - expression

KW - progression

KW - regulation

KW - transcription factors

KW - transforming growth factor α

KW - transforming growth factor β

UR - http://www.scopus.com/inward/record.url?scp=0027420305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027420305&partnerID=8YFLogxK

U2 - 10.1007/BF00665958

DO - 10.1007/BF00665958

M3 - Article

C2 - 8281613

AN - SCOPUS:0027420305

VL - 12

SP - 275

EP - 286

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 3-4

ER -